Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • RESEARCH HIGHLIGHT

Targeting viruses in their phase

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Nature Reviews Drug Discovery 20, 667 (2021)

doi: https://doi.org/10.1038/d41573-021-00129-0

This article originally appeared in Nat. Rev. Mol. Cell Biol. (https://doi.org/10.1038/s41580-021-00400-7)

References

  1. Wang, S. et al. Targeting liquid–liquid phase separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS activity. Nat. Cell Biol. https://doi.org/10.1038/s41556-021-00710-0 (2021)

  2. Risso-Ballester, J. et al. A condensate-hardening drug blocks RSV replication in vivo. Nature https://doi.org/10.1038/s41586-021-03703-z (2021)

Download references

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links